Chris Gaskell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chris Gaskell has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Gregg Harry Rawlings
Clinical and Applied Psychology Unit, University of Sheffield, UK
9 shared publications - Markus Reuber
Academic Neurology Unit, University of Sheffield, Royal Hallamshire Hospital, Glossop Road, S10 2JF Sheffield, UK
5 shared publications - Melanie Simmonds-Buckley
Clinical and Applied Psychology Unit University of Sheffield Sheffield UK
4 shared publications - Stephen Kellett
University of Sheffield Sheffield UK
4 shared publications - Jaime Delgadillo
King's College London
3 shared publications - Barbora Novakova
Health and Wellbeing Service, Sheffield IAPT Sheffield Health and Social Care NHS Foundation Trust Sheffield UK
2 shared publications
Latest Publications
- 29 September 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 143, 110-118
Psychosocial correlates of seizure frequency in Functional/Dissociative Seizures (FDS): A systematic review
- 29 September 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 143, 110-118
Psychosocial correlates of seizure frequency in Functional/Dissociative Seizures (FDS): A systematic review
- 28 July 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 141, 223-232
The prevalence of post-traumatic stress disorder in functional / dissociative seizures: A systematic review and meta-analysis
- 28 July 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 141, 223-232
The prevalence of post-traumatic stress disorder in functional / dissociative seizures: A systematic review and meta-analysis
- Open Access
- 22 July 2026
- Published by Elsevier in Radiography
- Vol. 32 (6) , 103488
Measuring “Scanxiety”: A Systematic Review and Symptom Coverage Analysis of Commonly Used Measures
- 22 July 2026
- Published by Elsevier in Radiography
- Vol. 32 (6) , 103488
Open AccessMeasuring “Scanxiety”: A Systematic Review and Symptom Coverage Analysis of Commonly Used Measures
- 17 March 2026
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 70 (6) , 653-663
Development and Validation of the Outcomes of WeLlbeing and Distress Scale for Adults With an Intellectual Disability (OWLS‐ID), Formally Known as the PTOS‐ID
Background: The Psychological Therapies Outcome Scale—Intellectual Disabilities‐II (PTOS‐ID‐II) is a 29‐item self‐report measure developed to assess psychological distress and positive well‐being in people with an intellectual disability. While initial validation demonstrated promising psychometric properties, further replication in a larger sample was needed, and incorporating insights gained from routine clinical use over the years since its initial implementation. Method: A quantitative cross‐sectional design was utilised to test the psychometric properties of the PTOS‐ID‐II using data collected from routine clinical practice from adults with intellectual disabilities ( n = 879) accessing a community health service. Subsequent analyses included dimensionality reduction (via principal component analysis and confirmatory factor analysis), assessment of internal consistency, concurrent validity and receiver operating characteristic analysis. Analyses were guided by a primer on the development of health outcome measures. Results: Exploration of the proposed factor structure of the PTOS‐ID‐II indicated that two of the items were problematic and subsequently removed. The new 27‐item measure was rebranded ‘the Outcomes for Wellbeing and Distress Scale’ (OWLS‐ID). Analysis of the measure identified and confirmed a three‐component model: (1) Positive Well‐being, (2) Emotional and Behavioural Discomfort and (3) Anxiety. Internal consistency was good to acceptable. Items related to Emotional and Behavioural Discomfort and Anxiety were combined to create a measure of psychological distress. Concurrent validity between distress as measured using the OWLS‐ID and Brief Symptoms Inventory was strong. A cut of 11.5 had acceptable sensitivity (0.85) and specificity (0.9). Analysis of missing data suggested that item acceptability was high. Conclusion: The OWLS‐ID is one of the most comprehensively tested patient‐reported outcome measures to date, which was developed specifically for individuals with an intellectual disability. Its implications for clinical practice and future research are discussed.
- 17 March 2026
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 70 (6) , 653-663
Development and Validation of the Outcomes of WeLlbeing and Distress Scale for Adults With an Intellectual Disability (OWLS‐ID), Formally Known as the PTOS‐ID
Background: The Psychological Therapies Outcome Scale—Intellectual Disabilities‐II (PTOS‐ID‐II) is a 29‐item self‐report measure developed to assess psychological distress and positive well‐being in people with an intellectual disability. While initial validation demonstrated promising psychometric properties, further replication in a larger sample was needed, and incorporating insights gained from routine clinical use over the years since its initial implementation. Method: A quantitative cross‐sectional design was utilised to test the psychometric properties of the PTOS‐ID‐II using data collected from routine clinical practice from adults with intellectual disabilities ( n = 879) accessing a community health service. Subsequent analyses included dimensionality reduction (via principal component analysis and confirmatory factor analysis), assessment of internal consistency, concurrent validity and receiver operating characteristic analysis. Analyses were guided by a primer on the development of health outcome measures. Results: Exploration of the proposed factor structure of the PTOS‐ID‐II indicated that two of the items were problematic and subsequently removed. The new 27‐item measure was rebranded ‘the Outcomes for Wellbeing and Distress Scale’ (OWLS‐ID). Analysis of the measure identified and confirmed a three‐component model: (1) Positive Well‐being, (2) Emotional and Behavioural Discomfort and (3) Anxiety. Internal consistency was good to acceptable. Items related to Emotional and Behavioural Discomfort and Anxiety were combined to create a measure of psychological distress. Concurrent validity between distress as measured using the OWLS‐ID and Brief Symptoms Inventory was strong. A cut of 11.5 had acceptable sensitivity (0.85) and specificity (0.9). Analysis of missing data suggested that item acceptability was high. Conclusion: The OWLS‐ID is one of the most comprehensively tested patient‐reported outcome measures to date, which was developed specifically for individuals with an intellectual disability. Its implications for clinical practice and future research are discussed.
- 15 January 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 135, 19-27
An e-Delphi approach to develop a patient-reported outcome measure to assess functional/dissociative seizures severity
- 15 January 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 135, 19-27
An e-Delphi approach to develop a patient-reported outcome measure to assess functional/dissociative seizures severity
- Open Access
- 19 December 2025
- Published by Cambridge University Press (CUP) in The Cognitive Behaviour Therapist
- Vol. 18
Cost and clinical effectiveness of mindfulness-based cognitive therapy for the prevention of depressive relapse in a primary mental health service: a pre–post and follow-up study
Depression is a highly common condition (World Health Organisation, 2022). Although many people demonstrate recovery there are marked levels of relapse. Mindfulness-based cognitive therapy (MBCT) is effective in preventing relapse. To date, the majority of studies do not primarily focus on the cost-effectiveness of MBCT within health care utilisation and workplace absenteeism. This study aims to explore the effectiveness of MBCT for prevention of depression relapse in patients attending a UK NHS primary care service. An observational (pre–post and follow-up) study of patients ( n =23) who experienced at least three depressive episodes were provided with MBCT. Cost-effectiveness was assessed using self-report measures of service utilisation and employment absence. These were assessed before MBCT, following, and 6 months post. Secondary outcomes assessing clinical effectiveness included measures of depression (PHQ-9), anxiety (GAD-7), and functional impairment (WSAS). There was a significant reduction in absenteeism at work and in health care usage and expenditure at the end of treatment. These improvements were continued during the follow-up period. Secondary outcomes indicated clinical improvements on depression, anxiety and functioning were maintained to follow-up. Key learning aims: (1) MBCT is a potentially cost-effective intervention in reducing absenteeism and health care usage for clients with recurrent depression. (2) In line with previous observations, MBCT is a clinically effective intervention for relapse prevention in recurrent depression as recommended by the National Institute for Health and Care Excellence (NICE). (3) Clinicians can consider the use of MBCT for clients with mild depression and recurrent depression within their services as recommended by NICE.
- 19 December 2025
- Published by Cambridge University Press (CUP) in The Cognitive Behaviour Therapist
- Vol. 18
Open AccessCost and clinical effectiveness of mindfulness-based cognitive therapy for the prevention of depressive relapse in a primary mental health service: a pre–post and follow-up study
Depression is a highly common condition (World Health Organisation, 2022). Although many people demonstrate recovery there are marked levels of relapse. Mindfulness-based cognitive therapy (MBCT) is effective in preventing relapse. To date, the majority of studies do not primarily focus on the cost-effectiveness of MBCT within health care utilisation and workplace absenteeism. This study aims to explore the effectiveness of MBCT for prevention of depression relapse in patients attending a UK NHS primary care service. An observational (pre–post and follow-up) study of patients ( n =23) who experienced at least three depressive episodes were provided with MBCT. Cost-effectiveness was assessed using self-report measures of service utilisation and employment absence. These were assessed before MBCT, following, and 6 months post. Secondary outcomes assessing clinical effectiveness included measures of depression (PHQ-9), anxiety (GAD-7), and functional impairment (WSAS). There was a significant reduction in absenteeism at work and in health care usage and expenditure at the end of treatment. These improvements were continued during the follow-up period. Secondary outcomes indicated clinical improvements on depression, anxiety and functioning were maintained to follow-up. Key learning aims: (1) MBCT is a potentially cost-effective intervention in reducing absenteeism and health care usage for clients with recurrent depression. (2) In line with previous observations, MBCT is a clinically effective intervention for relapse prevention in recurrent depression as recommended by the National Institute for Health and Care Excellence (NICE). (3) Clinicians can consider the use of MBCT for clients with mild depression and recurrent depression within their services as recommended by NICE.
- Open Access
- 2 September 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (3) , e002956
Restraint reduction during psychiatric intensive care: a controlled bi-phasic time series evaluation of a culture change intervention
Background: Restrictive practices (ie, physical restraint, rapid tranquilisation and seclusion) are used to manage risk of harm to self and/or others during inpatient psychiatric admissions. Restrictive practices can be physically and psychologically hazardous for both patients and staff, but there have been few well-controlled evaluations of interventions to reduce restrictive practices. Objective: To conduct a controlled evaluation of the implementation of a culture change intervention on a psychiatric intensive care unit (PICU) compared with a control PICU on use of restraint. Methods: A new staff role was created on the intervention PICU (ie, the reducing restrictive interventions advocate; RRIA). The RRIA met with patients/carers and advised, trained, supervised and debriefed the multidisciplinary team concerning restraint. Mixed methods evaluated the effectiveness of the RRIA role. Restraint outcomes on the intervention and the control PICU were compared pre (19 months) and post intervention (19 months). Qualitative interviews were conducted with the RRIA, the PICU ward manager and the RRI organisational lead. Results: On the intervention PICU, there were significant reductions in the use of seclusion, full restraint and use of standing holds. Qualitatively, positive changes to the safety culture of the intervention PICU were reported, and these were consistently rated as important, impactful and unlikely without the RRIA role. Conclusions: PICU safety culture can improve when specific roles focused on changing ward practices around restraints are implemented. More controlled evaluations of reducing restraint interventions on PICUs are needed.
- 2 September 2025
- Published by BMJ in BMJ Open Quality
- Vol. 14 (3) , e002956
Open AccessRestraint reduction during psychiatric intensive care: a controlled bi-phasic time series evaluation of a culture change intervention
Background: Restrictive practices (ie, physical restraint, rapid tranquilisation and seclusion) are used to manage risk of harm to self and/or others during inpatient psychiatric admissions. Restrictive practices can be physically and psychologically hazardous for both patients and staff, but there have been few well-controlled evaluations of interventions to reduce restrictive practices. Objective: To conduct a controlled evaluation of the implementation of a culture change intervention on a psychiatric intensive care unit (PICU) compared with a control PICU on use of restraint. Methods: A new staff role was created on the intervention PICU (ie, the reducing restrictive interventions advocate; RRIA). The RRIA met with patients/carers and advised, trained, supervised and debriefed the multidisciplinary team concerning restraint. Mixed methods evaluated the effectiveness of the RRIA role. Restraint outcomes on the intervention and the control PICU were compared pre (19 months) and post intervention (19 months). Qualitative interviews were conducted with the RRIA, the PICU ward manager and the RRI organisational lead. Results: On the intervention PICU, there were significant reductions in the use of seclusion, full restraint and use of standing holds. Qualitatively, positive changes to the safety culture of the intervention PICU were reported, and these were consistently rated as important, impactful and unlikely without the RRIA role. Conclusions: PICU safety culture can improve when specific roles focused on changing ward practices around restraints are implemented. More controlled evaluations of reducing restraint interventions on PICUs are needed.
- Open Access
- 28 August 2025
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 40 (7) , 1444-1452
Practice Effects and Long Delays: A Case Report Exploring a Novel Approach to Detecting Accelerated Long-Term Forgetting
Objective: Accelerated Long-Term Forgetting (ALF) is when newly learned information “decays” faster than expected over an extended period and is associated with temporal-lobe epilepsy (TLE). There is no well-established method for assessing ALF despite its apparent prevalence. We hypothesized that evidencing an absence of practice effects may represent an effective approach to detecting ALF. We sought to determine if this method, along with the long-delay memory tests, could evidence ALF in a single case. Method: We present a 66-year-old male with TLE who had memory complaints despite a stable memory profile over 4 years. Memory tests that employ a short (20–30 min) and a long delay (4 days) condition were used to assess forgetting, whereas repeatedly administered tests were used to detect practice effects. We anticipated poorer memory performance on the long versus short-delay test condition and a lack of improvement on memory tests that were repeated. Results: For repeat administration tests, there was a marked score increase, indicating practice effects, for verbal and visual domains. For long delay tests, however, there was a notable drop with retention falling in the exceptionally low range. Conclusions: These findings suggest a dissociation between long delay and serial assessment tasks for detecting ALF.
- 28 August 2025
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 40 (7) , 1444-1452
Open AccessPractice Effects and Long Delays: A Case Report Exploring a Novel Approach to Detecting Accelerated Long-Term Forgetting
Objective: Accelerated Long-Term Forgetting (ALF) is when newly learned information “decays” faster than expected over an extended period and is associated with temporal-lobe epilepsy (TLE). There is no well-established method for assessing ALF despite its apparent prevalence. We hypothesized that evidencing an absence of practice effects may represent an effective approach to detecting ALF. We sought to determine if this method, along with the long-delay memory tests, could evidence ALF in a single case. Method: We present a 66-year-old male with TLE who had memory complaints despite a stable memory profile over 4 years. Memory tests that employ a short (20–30 min) and a long delay (4 days) condition were used to assess forgetting, whereas repeatedly administered tests were used to detect practice effects. We anticipated poorer memory performance on the long versus short-delay test condition and a lack of improvement on memory tests that were repeated. Results: For repeat administration tests, there was a marked score increase, indicating practice effects, for verbal and visual domains. For long delay tests, however, there was a notable drop with retention falling in the exceptionally low range. Conclusions: These findings suggest a dissociation between long delay and serial assessment tasks for detecting ALF.
- 3 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 173, 110567
What determines the severity of functional/dissociative seizures? Views of patients and healthcare professionals
- 3 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 173, 110567
What determines the severity of functional/dissociative seizures? Views of patients and healthcare professionals
- Open Access
- 25 May 2024
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 119, 98-109
A meta-analytic evaluation of the effectiveness and durability of psychotherapy for adults presenting with functional dissociative seizures
- 25 May 2024
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 119, 98-109
Open AccessA meta-analytic evaluation of the effectiveness and durability of psychotherapy for adults presenting with functional dissociative seizures